ALACHUA, Fla.–(BUSINESS WIRE)–RTI Surgical® Inc. (RTI) (Nasdaq: RTIX), a leading global surgical implant company, is pleased to announce the market launch of the Release® Laminoplasty Fixation System. The Release System provides an efficient, streamlined surgical experience that allows for central spinal cord decompression from C3 to T3 in laminoplasty procedures.
The Release System consists of plates and screws that secure the opened lamina to the lateral mass at each affected level, maintaining expansion of the spinal canal. The system’s low-profile plate minimizes the risk of plate impingement on adjacent, healthy facet joints, and the screw design features a thread form that enhances bone purchase.
“With the addition of the Release Laminoplasty Fixation System to our spine portfolio we are able to enter the posterior laminoplasty market, which is a new market segment for us,” said Brian K. Hutchison, president and CEO of RTI Surgical. “We continue to expand our portfolio in our spine hardware business with safe implants that address important clinical needs.” 
About RTI Surgical Inc.
RTI Surgical is a leading global surgical implant company providing surgeons with safe biologic, metal and synthetic implants. Committed to delivering a higher standard, RTI’s implants are used in sports medicine, general surgery, spine, orthopedic, trauma and cardiothoracic procedures and are distributed in nearly 50 countries. RTI is headquartered in Alachua, Fla., and has four manufacturing facilities throughout the U.S. and Europe. RTI is accredited in the U.S. by the American Association of Tissue Banks and is a member of AdvaMed. For more information, please visit www.rtix.com.
Forward Looking Statement
This communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s current expectations, estimates and projections about our industry, our management’s beliefs and certain assumptions made by our management. Words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” variations of such words and similar expressions are intended to identify such forward-looking statements. In addition, except for historical information, any statements made in this communication about anticipated financial results, growth rates, new product introductions, future operational improvements and results or regulatory actions or approvals or changes to agreements with distributors also are forward-looking statements. These statements are not guarantees of future performance and are subject to risks and uncertainties, including the risks described in public filings with the U.S. Securities and Exchange Commission (SEC). Our actual results may differ materially from the anticipated results reflected in these forward-looking statements. Copies of the company’s SEC filings may be obtained by contacting the company or the SEC or by visiting RTI’s website at www.rtix.com or the SEC’s website at www.sec.gov.
For more information about the Release Laminoplasty Fixation System, please contact customer service at 1-888-778-8771.
® indicates U.S. trademark registration
Contacts
RTI Surgical Inc.
Ryan Gerds, APR, CPRC, 386-418-8888
Director, Marketing Communications
rgerds@rtix.com